By Richard A. Lewis, MD, Chief Medical Editor
Several presentations had relevance for how clinicians manage and treat patients with glaucoma.
By Albert S. Khouri, MD
Clinicians share their advice on determining which patients to treat.
By Allison Angelilli, MD; Jeffrey M. Liebmann, MD; Arthur J. Sit, SM, MD; and Anjali M. Bhorade, MD, MS
A report on some of the newly available options for covering a tube.
By Steven R. Sarkisian, Jr, MD
Advances in technology are helping ophthalmologists expand their diagnostic and therapeutic boundaries.
By Louis R. Pasquale, MD
Pearls for enhancing the results of ab interno trabeculotomy.
By Steven D. Vold, MD
An update on products with potential for glaucoma therapy.
By Gary D. Novack, PhD
Anatomy alone cannot account for who develops this disease and who does not.
By Harry A. Quigley, MD
Beyond relative pupillary blockâidentifying alternative mechanisms for primary angle closure with advanced technology.
By Jason A. Goldsmith, MD, MS
A thorough workup detects congenital changes in a patient's crystalline lenses.
By Tania Paul, MD, and Nathan M. Radcliffe, MD
By Mark Werner, MD
Tips for effective public speaking.
By Julia T. Lewandowski, Senior Associate Editor
Dr. Melamed discusses the value of glaucoma screenings and the beauty of his rare birds.
By Shlomo Melamed, MD
brAlcon Laboratories, Inc. (Fort Worth, TX), has suspended the development of anecortave acetate for the treatment of elevated IOP associated with glaucoma. Earlier this year, investigators reported that the mean IOPs of six eyes ... more >
brHealth Canada cleared the Solx Gold Shunt (Solx, Inc., Waltham, MA) for clinical use in Canada. According to a news release from the company, Solx's GMS+ Gold shunt "reduced IOP by 45.6% from best medicated baseline in patients ... more >
brTranscend Medical (Menlo Park, CA) has raised $35 million in series B funding for the development of its CyPass glaucoma treatment system. A report prepared by Snowdon & Associates (West Vancouver, British Columbia, Canada) ... more >
brA prospective, open-label study showed a significant disparity between patients' perceived versus observed ability to instill hypotensive eye drops.sup1/sup Glaucoma specialists from Baltimore analyzed 181 videos of 139 pati... more >
An update on products with potential for glaucoma therapy.
By Gary D. Novack, PhD
Anatomy alone cannot account for who develops this disease and who does not.
By Harry A. Quigley, MD
By Mark Werner, MD
A report on some of the newly available options for covering a tube.
By Steven R. Sarkisian, Jr, MD
Advances in technology are helping ophthalmologists expand their diagnostic and therapeutic boundaries.
By Louis R. Pasquale, MD